ArticleBiomolecules2026
AUKAT: Conditional VAE-Driven Augmentation and Neural Modeling of Enzyme Turnover Numbers.
Article in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate prediction of enzyme turnover numbers (kcat) is essential for applications in systems biology, metabolic engineering, and drug discovery, yet remains challenging due to the limited availability and uneven distribution of experimental data. Here, we present AUKAT, an integrated framework that combines conditional generative modeling with deep neural prediction to improve kcat estimation. A conditional variational autoencoder generates synthetic training instances in embedding space, followed by a selection pipeline that retains samples with strong agreement across independent evaluators, thereby ensuring data reliability. A hybrid convolutional neural network and transformer-based architecture is then used to predict kcat from substrate, enzyme functional, and species embeddings. Incorporating synthetic data improved predictive performance for both random forest and neural network models in five-fold cross-validation, with larger gains observed for the neural network architecture. Benchmarking against DLKcat demonstrated comparable predictive accuracy on the standard test set, while evaluation on stricter unseen subsets indicated improved generalization for low-similarity substrates and enzymes. Feature importance analysis further showed that AUKAT leverages substrate, enzyme functional, and species information in a more balanced manner rather than relying predominantly on a single feature source. In addition, AUKAT-human, a specialized model trained using a pre-training and fine-tuning strategy, achieved improved prediction accuracy for human enzyme kinetics. Overall, AUKAT provides a scalable approach for enzyme kinetics prediction and offers a practical solution to data scarcity in biochemical modeling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.